Guided Therapeutics (GTHP) Inventory Average (2012 - 2025)
Guided Therapeutics recorded quarterly Inventory Average of $515500.0 in Q4 2025, down 12.48% quarter-over-quarter from $589000.0 in Q3 2025, and down 18.75% year-over-year from $634500.0 in Q4 2024.
Guided Therapeutics' Inventory Average history runs 14 years deep, the most recent figure standing at $515500.0 for Q4 2025.
- In Q4 2025, Inventory Average fell 18.75% year-over-year to $515500.0; the TTM figure through Dec 2025 stood at $515500.0 (down 18.75% YoY), while the FY2025 annual figure was $540500.0, down 14.55% from the prior year.
- Inventory Average came in at $515500.0 for Q4 2025 at Guided Therapeutics, down from $589000.0 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $640000.0 in Q4 2023 to a low of $515500.0 in Q4 2025.
- A 5-year average of $599475.0 and a median of $608000.0 in 2021 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average soared 1074.04% in 2021 and dropped 18.75% in 2025, its largest moves.
- Guided Therapeutics' Inventory Average stood at $580500.0 in 2021, then decreased by 1.46% to $572000.0 in 2022, then gained by 11.89% to $640000.0 in 2023, then fell by 0.86% to $634500.0 in 2024, then decreased by 18.75% to $515500.0 in 2025.
- According to Business Quant data, Inventory Average over the past three periods registered $515500.0, $589000.0, and $614000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.23 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.49 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 661.35 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 652.65 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 515,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 515,500.00 |
| Sep 30, 2025 | 589,000.00 |
| Jun 30, 2025 | 614,000.00 |
| Mar 31, 2025 | 633,000.00 |
| Dec 31, 2024 | 634,500.00 |
| Sep 30, 2024 | 634,000.00 |
| Jun 30, 2024 | 632,000.00 |
| Mar 31, 2024 | 632,000.00 |
| Dec 31, 2023 | 640,000.00 |
| Sep 30, 2023 | 610,500.00 |
| Jun 30, 2023 | 579,000.00 |
| Mar 31, 2023 | 566,500.00 |
| Dec 31, 2022 | 572,000.00 |
| Sep 30, 2022 | 582,500.00 |
| Jun 30, 2022 | 569,500.00 |
| Mar 31, 2022 | 570,500.00 |
| Dec 31, 2021 | 580,500.00 |
| Sep 30, 2021 | 610,500.00 |
| Jun 30, 2021 | 618,500.00 |
| Mar 31, 2021 | 605,500.00 |
| Dec 31, 2020 | 329,000.00 |
| Sep 30, 2020 | 52,000.00 |
| Jun 30, 2020 | 54,000.00 |
| Mar 31, 2020 | 52,500.00 |
| Dec 31, 2019 | 48,000.00 |
| Sep 30, 2019 | 48,000.00 |
| Jun 30, 2019 | 80,000.00 |
| Mar 31, 2019 | 113,000.00 |
| Dec 31, 2018 | 189,500.00 |
| Sep 30, 2018 | 272,500.00 |
| Jun 30, 2018 | 287,500.00 |
| Mar 31, 2018 | 238,500.00 |
| Dec 31, 2017 | 379,500.00 |
| Sep 30, 2017 | 666,500.00 |
| Jun 30, 2017 | 796,000.00 |
| Mar 31, 2017 | 804,500.00 |
| Dec 31, 2016 | 972,000.00 |
| Sep 30, 2016 | 1.20 Mn |
| Jun 30, 2016 | 1.25 Mn |
| Mar 31, 2016 | 1.19 Mn |
| Dec 31, 2015 | 1.02 Mn |
| Sep 30, 2015 | 948,500.00 |
| Mar 31, 2014 | 597,127.00 |
| Dec 31, 2013 | 596,905.00 |
| Sep 30, 2013 | 708.50 |
| Jun 30, 2013 | 523.00 |
| Mar 31, 2013 | 262,219.50 |
| Dec 31, 2012 | 492,568.00 |
| Sep 30, 2012 | 460,089.50 |